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In 191I  Morgenroth and Levy  (I)  introduced the drug ethylhy- 
drocuprein (optochin), a derivative of hydroquinine, in the treatment 
of experimental pneumococcic infection.  Subsequent tests have, as 
a  rule, shown the compound to possess a  parasiticidal effect on the 
pneumococci.  In the experiments so far reported, different strains 
of pneumococci, chosen more  or lessat  hazard,  were studied;  no 
attempt, however,  has  been made to  investigate the action  of the 
drug  on  type  strains  of  the  various  groups  of  pneumococci.  It 
seemed of interest to investigate the action of the drug  from this 
viewpoint. 
Neufeld  (2)  showed  that strains of  pneumococci  differed  among  themselves 
in  respect  to  their  immunity  reactions  (protective  bodies).  The  investigations 
of Cole  (3)  and of Dochez and Gillespie  (4)  have resulted in a  serological classi- 
fication of the pneumococci.  It has been shown by these authors that the pneumo- 
cocci can be divided into at  least four groups.  The organisms  of  Groups  I  and 
II  are  specific in  their immunity reactions;  that is,  an  immune  serum  produced 
against  any  member  of  Group  I  has  a  specific  protective  action  against,  and  a 
specific  agglutinative  action  on,  any  member  of  Group  I,  but  has  no  effect  on 
any members of Groups II,  III,  or IV.  Similarly,  a  serum immune to any mem- 
ber of  Group  II will react in the same  way with all members of  that group,  but 
not  with  any members  of  Groups  I,  III,  or  IV.  In  Group  III  are  included  all 
members  of  the  Pneumococcus  mucosus  type.  To  Group  IV  belong  all  pneu- 
mococci not belonging to Groups  I,  II,  or III.  A  serum immune to any member 
of  Group IV exhibits protective and agglutinative reactions with the  strain used 
for  its  production,  but  in  no  instance with  any  other  member  of  Group  IV  or 
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with any member of the other three groups.  Lister  (5)  has  arrived at  a  some- 
what  similar classification from opsonie studies. 
EXPERIMENTAL, 
The  pneumococci  used  in  the  present  study were  representative 
of these  four serological groups  and  were obtained  from  the  Hos- 
pital of The Rockefeller Institute,  with the exception of the micro- 
organism  designated  as  South  Africa  (9),  which  was  obtained 
from  the  South  African  Institute  for  Medical  Research;  this  or- 
ganism  has  been placed  in  a  fifth  group  by Lister  (5)  as  a  result 
of  his  opsonic  studies.  All  strains  of  pneumococci  used  in  the 
present study were isolated from cases of human pneumonia,  except 
those  called  I  Les  and  II  White,  which  were obtained  from  cases 
of pneumococcal meningitis  by lumbar puncture. 
The Action  of Ethylhydrocuprein  in  Nitro. 
Wright  (6)  has  shown  that  the  action  of  ethylhydrocuprein  hy- 
drochloride on pneumococci in vitro is only slightly lessened by the 
presence  of serum,  while with antiseptics  such  as  lysol and  cresol, 
under  similar  conditions,  the  contrary  is  the  case.  Tugendreich 
and  Russo  (7)  have  shown that  the  hydrochloride  of  the  drug  in 
a  concentration  of  I  in  I6,ooo kills  the  pneumococcus  in vitro  in 
three  hours  at  room temperature,  and  that  it  is much more potent 
in  this  respect  than  the  hydrochlorides  of  the  homologous  com- 
pounds:  isopropyl,  isobutyl,  and  isoamylhydrocuprein;  this  su- 
periority is even more marked  over quinine  and  hydroquinine.  In 
the present study the action of ethylhydrocuprein  hydrochloride  on 
type strains  of the different groups of pneumococci was worked out 
and  compared  with  that  on  other  microorganisms  under  similar 
conditions. 
Technique.--A solution of the drug was made in broth and ster- 
ilized  by boiling  or filtration  through  a  Berkefeld  filter.  Various 
dilutions of this stock solution were made;  to 2  cc.  of each dilution 
in  a  test-tube  o.I  cc.  of  a  24  hour  broth  culture  was  added  and 
the  tubes  were  incubated  for  18  hours  at  37 °  C.  At  the  end  of 
this  period  the  tubes  were  examined,  and  the  results,  as  regards 
growth  or inhibition  of  growth,  noted;  a  large  loopful of the  two Henry F..Moore.  271 
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lowest dilutions  showing growth macroscopically,  and  of all  tubes 
showing  no  growth,  was  in  each  case  plated  in  about  12  cc.  of 
blood  agar  and  incubated.  The  concentration  of  the  drug  was 
thus enormously diluted.  The plates were examined at the end of 
24 hours  and  again at the end of 48 hours.  Thus,  one could dif- 
ferentiate  between an  inhibitory  effect of  the  drug  on the  growth 
of the  microorganism  and  actual  death.  Some typical  results  are 
given in Table I. 
Explanation  of  Tables.--In  the  top  row  the  Roman  numeral 
stands  for  the  serological  group  to  which  the  strain  of  pneumo- 
coccus belongs;  a  letter and number  in brackets,  if present,  denote 
the  particular  strain;  the  Arabic  number  represents  the  number  of 
animal passages  of the strain  and the exponent the number  of cul- 
tivations on artificial medium since the last animal passage.  In the 
remaining  two  rows  each  number  represents  the  greatest  dilution 
in  which the  growth  of  the  corresponding  microorganism  was  in- 
hibited  or killed,  as the case may be.  In the  case of the pneumo- 
~:occi the range  of dilutions  of the drug examined  was  as  follows: 
I  in Io,ooo; I  in 2o,ooo; I  in 5o,ooo; x in xoo,ooo; I  in 5oo,ooo; I 
in  I,ooo,ooo; and  ~ in  Io,ooo,ooo. 
From the results given in Table I  it is seen that ethylhydrocuprein 
hydrochloride  causes in very high  dilutions,  in vitro,  an  inhibition 
of growth, and death of the pneumococcus, the latter occurring, gen- 
erally speaking, in somewhat lower dilutions ; and that no constant or 
considerable  differences  are  seen  in  these  effects  on  typical  repre- 
sentatives of the four groups of pneumococci. 
It was thought of interest to compare the action on pneumococci 
with  that  on  other  organisms,  more  especially  streptococci.  The 
results are  set  forth  in  Table II. 
Description  of the Microorganisms Mentioned  in  Table II. 
Streptococcus  I  was  a  non-hemolytic  streptococcus  cultivated by  Dr.  Beattie 
from  a  case of  rheumatic  fever.  The  culture  used  was  obtained  from the  Bac- 
teriological  Department  of  the  Museum  of  Natural  History,  New  York. 
Streptococci 5  and 7 were two  different strains of non-hemolytic streptococci 
obtained  from  the  Pathological  Department  of  Mr.  Sinai  Hospital,  New  York. 
They  were  cultivated  from  the  'blood  of  patients  suffering  from  sabacute 
endocarditis. Henry  F. Moore.  273 
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Streptococcus 8 was a  laboratory strain  of hemolytic streptococcus. 
Streptococcus  59  was  a  green-producing,  non-hemolytic streptococcus  culti- 
vated by Dr. H. F.  Swift from the blood of a patient  suffering from rheumatic 
pericarditis. 
None of these  strains  had a  capsule,  fermented  inulin,  or was bile-soluble. 
The  Streptococcus ~nucosus was  a  diplococcus growing  in  short  chains;  it 
showed, with His's stain,  a well defined  capsule in the body fluids  of an infected 
animal;  it  was  not  bile-soluble;  it  was  pathogenic  for  mice,  causing  a  sticky 
exudate in the peritoneal  cavity; it  did not ferment inulin;  on cultivation  for a 
few  passages  on  blood  agar  the  growth,  which  was  previously moist  on  solid 
media,  became dry in character. 
The streptococcus strains  called  R  and  C were isolated  from normal sputum 
and were mucous in type; that is, they gave a mucoid growth on blood agar and 
possessed a capsule; these qualities  were,  however,  lost after a  few passages on 
artificial media.  Neither was bile-soluble,  and neither  fermented  inulin. 
From  Table  II  it  is  seen  that  the  action,  if  any,  of  ethylhydro- 
cuprein,  in the dilutions  examined,  on the microorganism  mentioned 
therein  was  considerably  less  than  that  on  the  pneumococci. 
The action in vitro of the hydrochloride  of quinine  (from  which 
ethylhydrocuprein  is  derived)  on  pneumococci  and  on  some  other 
microorganisms  is  shown  in  Table  III.  It  is  seen  therefrom  that, 
while  the  action  of  quinine  hydrochloride  is  greater  on  the  pneu- 
mococci  than  on  the  other  bacteria,  this  action  is  far  less  in  the 
former  case  than  that  of  optochin. 
The  Action  of Ethylhydrocuprein  (Opt,  ochin  Base)  on  Represen- 
tatives of the Four Groups tof Pneumococci in Uivo. 
Owing  to the  fact that  certain  biochemical  relationships  (such as 
bile  solubility)  exist  between  trypanosomes  (8)  and  spirilla  (9), 
on  the  one  hand,  and  the  pneumococci  (IO)  alone  among  the  Co- 
cacece,  on  the  other,  Morgenroth  (I)  investigated  the  action  on 
the  pneumococci  of  that  group  of  compounds  which  has  given  re- 
sults  in  the  therapy  of  trypanosomal  and  spirillar  infections; 
namely,  quinine  and  its  derivatives. 
]Y[orgenroth and Levy showed that ethylhydrocuprein  (a derivative of hydro- 
quinine)  exerted a considerable protective action, and a certain  degree of curative 
action  (I)  on  experimental  pneumococcal infection  in  the  mouse.  Later  Gut- 
mann  (II)  and Morgenroth and Kaufmann  (I2)  reported experiments  in which 
this protective action on several strains  of pneumococci was shown.  Levy (13) 
studied  the curative effect of the  drug on pneumococcal infection of the mouse 
by a  strain  of Pneumococcus mucosus, an  interval  of  from  two  to  six  hours 
having been allowed to elapse between  the intraperitoneal  infection and the first 276  Action of Ethylhydrocuprein on Pneumococci. 
administration of  the drug.  The  dosage of the infection does not seem  to  have 
been accurately measured in Levy's experiments, nor do the results seem to have 
been checked  by  autopsy;  an  effect  of  the  drug,  however,  on  the  infection  can 
be seen ; of  16 mice, IO survived up to the 8th day, when the observation was dis- 
continued.  This  work  is  summarized by Rosenthal  (14). 
So  far,  the  strains  studied  in  this  connection  were chosen  more 
or less at haphazard,  no attempt having been made to study strains 
of pneumocoeci in  relation  to classification.  In  the  following ex- 
periments  typical  representatives  of  the  four  groups  of  pneumo- 
cocci were used. 
Technique.--A  2  per  cent  solution  of the  free  base ethylhydro- 
cuprein  (optochin  base)  was  made  in  sterile  olive  oil  by rubbing 
up  in  a  mortar  and  standing  the  product  so obtained  in  the  incu- 
bator at 37 ° C. over night.  Mice of 18 grams'  weight and upwards 
were used.  The infection was given in a  constant volume of  I  cc. 
of  broth  intraperitoneally.  The  treatment  consisted  of  o. 5  cc.  of 
the  2  per  cent  optochin  base  solution  in  oil  (calculated  in  every 
case)  per 2o grams  of mouse given under the skin of the back imme- 
diately after the  infection;  this  was  followed by an  equal  dose  on 
the second day of the  experiment,  and  by o.4 cc.  per 2o  grams  of 
mouse on the third  and  fourth days.  The mice were observed for 
a period of from IO to 14 days.  An autopsy was performed on every 
mouse  that  succumbed  (whether  a  treated  animal  or  a  control), 
and  the  heart's  blood,  and  peritoneal  fluid  if  necessary,  were  ex- 
amined in a smear preparation,  Gram's stain and His's capsule stain 
being  used.  If  no  Gram-positive  and  capsule-bearing  bacteria 
were found in the  smear by these methods,  cultures  were made  on 
defibrinated  rabbit  blood  agar  with  abundant  inoculation,  incu- 
bated  for 24 hours  at 37 °  C.,  and then  examined. 
In  tabulating  the  results  the  graphic  method  recommended  by 
Morgenroth  is  employed.  In  the  text-figures  each  square  denotes 
one experimental animal;  a black square indicates death from pneu- 
mococcal  septicemia;  a  white  square,  survival;  an  oblique  cross 
denotes that the animal died, but that the examination of the heart's 
blood was negative, in which instance death  was apparently  caused 
by the toxicity of the drug,  the infecting pneumococei having been 
first killed  off by its action ;1  and,  finally,  a  square subdivided into 
1 Morgenroth  pointed  out  that  the  toxic  dose  for  mice  is  not  far  removed 
from the curative dose. Henry  F.  Moore.  277 
six  smaller  ones  denotes  that  the  animal  was  sick  at  the  time  of 
observation  (Text-fig.  I). 
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TExT-FIG.  I.  Explanation of  the method  used  in the  text-figures. 
The condition of the animals  is first given in the diagram  on the 
second day of the experiment;  that  is, 24 hours  after the infection 
and first treatment;  consequently, the first diagram  in each experi- 
ment is marked 2d day. 
The minimum  lethal  dose of the infecting  microorganism  was in 
each case determined  for forty-eight hours unless otherwise stated; 
in all cases that  dose was taken  as the m.  1.  d. which was with cer- 
tainty  fatal within  the  time  limit  stated  for several mice.  In case 
of  doubt reestimations  were  made.  With  this  statement  it  is  un- 
necessary to give the estimations  in detail. 
Throughout the observations the mice were kept at about 75 °  F.2 
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TExT-FIG.  2.  Experiment  i.  Strain  I  IO6.  4  The re.I.d,  was  o.ooo,o(x~,(~i  ec. 
(48  hrs.).  The  infecting  doses  used:  io  re.I.d.  (Column  A);  I,~  m.l.d. 
(Column  B).  Column  C,  controls  (untreated). 
2 The  toxicity  of  the  drug  is  said  to  be  greater  when  the  animals  are  kept 
exposed  to  cold. 278  Action of Ethylhydrocuprei~,  on Pneumococci. 
Comment  on  E.rperiment  ±.--(Text-fig.  2.)  Of  the  6  treated 
animals  infected  with  IO times  the  m.  1.  d.,  2  died  of toxicity, the 
heart's blood at autopsy being sterile ; while the remaining 4 animals 
remained  permanently well;  of those infected with  I,OOO times  the 
m.  I.  d.  and  treated,  I  died  of  toxicity  (showing  sterile  heart's 
blood at autopsy), and the remaining 4 of pneumococcal septicemia; 
the last mentioned 4  animals,  however,  survived much  longer  than 
the untreated  controls. 
This  microorganism  was  of  extraordinarily  high  virulence  for 
mice, it having had  lO6 animal passages.  The m.  1. d. above stated 
was  regularly  fatal  and  showed 6  to  14 colonies when plated. 
r~  ~  th  tb  2DAY  3DAY ]  ] 
0.1cq 
....  _ I.o,o 
A  B  C  D  A  B  C  D  A  B  C  D  &  B  C  D 
t~  th  th 
ABC  D  A.B  C  D  ABCD 
TExT-FIe.  3.  Experiment  2.  Strain  I  (B42)I ~.  The  m.l.d,  was  o.om  ce. 
The  infecting doses  used:  IO  m.l.d.  (Column  A) ;  IOO  m.l.d.  (Column  B) ;  500 
m.l.d.  (Column  C).  Column  D,  controls  (untreated). 
Comment  on  E~'periment  2.--(Text-fig.  3.)  This  strain  was 
relatively  much  less  virulent  than  the  previous  one.  A  dose  of 
o.ooi  cc.  or o.oi  cc.  was always fatal within 4  to 5 days, but some- 
times  the  animals  infected  with  the  larger  of these  doses  survived 
those infected with the smaller by a  day.  In view of the protracted 
course of the  infection  in  this  case the  time  limit  for  the  m.  1.  d. 
was  judged  as  5  days.  Of  those  animals  injected  with  IO  times 
the  m.  1.  d.  only  I  died of pnemnococcal  septicemia,  all  the  others Henry  F.  Moore.  279 
surviving.  Of those injected with IOO times the m. 1. d.  I survived; 
2 died of toxicity;  and 2 of pneumococcal septicemia, but later than 
the  controls. 
2~DAY  3rdDAY  4  DAY 
t+'H" 
l  I  l[ 
AB  C  AB  C  &  B  C 
tb 
5  DAY 
A  BC  A  B'O 
TExT-FIG.  4.  Experiment 3.  Strain  II  3419.  The m.l.d,  was o.ooo,ooo,ooi  cc. 
(48 hrs.).  The infecting doses:  IO m.l.d.  (Column A) ,  IOO rn.l.d.  (Column  B). 
Column  C,  controls  (untreated). 
Comment  on Experiment 3.--(Text-fig.  4.)  Of  the  4  animals 
infected with  Io times  the  m.  1.  d.  and  treated,  I  died  on the  6th 
day of pneumococcal septicemia and 3 survived.  Of the 5 infected 
with  IOO times the m.  1. d. and treated, 3 died of pneumococcal sep- 
ticemia and  I  survived;  the remaining animal died of toxicity.  On 
plating the m.  1.  d.,  6  to  I2 colonies resulted.  This  strain  was one 
of very high  virulence,  notwithstanding  the  fact that  it had  under- 
gone nineteen artificial cultivations  since the last animal  passage. 
nd 
TEXT-FIG.  5.  Experiment 4.  Strain  II  (B2I)  32.  The  m.l.d,  was  o.o,ooo,ooi 
cc.  (fatal  in  4  days).  Dose  used:  I,OOO m.l.d.  (Column  A).  Column  B,  con- 
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Comment  on  Experiment  4.--(Text-fig.  5-)  If  the  m.  1.  d.  is 
judged to kill in 4  days, 4  mice out of 6  infected with  I,OOO times 
the m.  1.  d.  survived the controls  permanently.  Of the  2  given in 
Text-fig.  5  as  dying  of  toxicity the  heart's  blood of  I  was  sterile, 
and a  Gram-negative bacillus was recovered from that of the other, 
but no pneumococci. 
2had  A'/  3Pd DAY  4  ~  5  th DAY 
ABC  A  B  C  A  B  C  A  B  C 
TExT-Fro. 6.  Experiment 4 a.  Strain II (B2I)214.  The m.l.d, was o.oi cc.  (48 
hrs.).  Doses  used:  I  m.l.d.  (Column  A);  50  m.l.d.  (Column  B).  Column  C, 
controls  (untreated). 
Comment  on  Experiment  4  a.--(Text-fig.  6.)  In  this  experi- 
ment  I  animal  represented  in  Column  A  (I  m.  1.  d.)  and  I  in 
Column  B  (5 °  times  the m.  1.  d.)  died on the  8th and  Ioth  days, 
respectively,  the  heart's  blood  showing  on  examination  a  Gram- 
negative  bacillus but no pneumococci.  As  we were troubled with 
mouse typhoid  at  this  time,  this  was probably the  cause  of  death. 
5  animals  survived,  2  died  of  pneumococcal  septicemia,  and  I  of 
toxicity. 
txt  rd  th  tb  tb 
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TEXT-FIG.  7-  Experiment 5.  Strain III (A66) I2'.  The m.l,d, was o.ooo, ooo, ooi 
cc.  (48 hrs.).  Doses used :  IO m.l.d.  (Column A) ;  IOO m.l.d.  (Column B) ;  I,OOO 
m.l.d.  (Column C).  Column D, controls  (untreated). Henry  F.  Moore.  281 
Comment  on  Experiment  5.--(Text-fig.  7.)  The  Strain  III 
(A  66)126  was  a  very virulent  one.  The  m.  1.  d.,  o.ooo,ooo,ooi 
cc.  of  a  24  hour  broth  culture,  when  plated  on  blood  agar, 
showed on incubation at least  15 typical colonies.  The animal  rep- 
resented  by  the  upper  segment  of  Column  C  was  found  almost 
completely eaten by its fellows on the 6th day;  no autopsy could be 
done, consequently the cause of death is somewhat doubtful.  After 
the 6th day no further deaths occurred in this  series.  5 out of  io 
animals  injected  with  IO  times  the  m.  1.  d.  survived;  3  died  of 
pneumococcal infection,  and  2  of toxicity  (giving  a  sterile  heart's 
blood).  Of 3  injected with  IOO times the m.  1. d.  2  survived,  and 
the remaining  animal succumbed to the infecting pneumococci.  Of 
those injected with  I,OOO times the m.  1. d. none survived. 
nl 
2  DAY 
A  R  C  BC 
TExT-FIG. 8.  Experiment 6.  Strain III  (E22)I26.  The m.l.d.  (o.ooo, ooi cc.) 
was  fatal in 48 hrs.  o.oo, ooo,ooi  cc.  of  a  broth culture  was  observed to  be regu- 
larly  fatal  within  four  days;  the  m.l.d,  was  not,  however,  at  the  time  of  this 
experiment determined  for  a  longer  period  than  48 hrs.;  consequently  the  dose 
of  o.ooo, ooi  cc.  was  probably considerably  greater  than  the  m.l.d,  for  a  mouse. 
Column A,  I  m.l.d.  (o.ooo, ooi  cc.  (48 hrs.)).  Column B,  IO m.l.d.  (o.oo,ooi  cc. 
(48 hrs.)).  Column  C,  controls,  I  m.l.d.  (untreated). 
Comment on Experiment 6.--(Text-fig.  8.)  Among the treated 
animals  no  death  occurred  up  to  the  Ioth  day  when  observation 
was discontinued.  I animal of the series died of toxicity, and none 
of pneumococcal septicemia. 3 
8 Further  experience  with this  strain has  shown  it to  be more  susceptible to 
the  action  of  ethylhydrocuprein in vivo  than  any  other  strain  of  pneumococcus 
examined  by  us.  We  have  been  able  with  the  drug  to  protect  against  IO,OOO 
times the m.l.d. 282  Action of Ethylhydrocuprein  on Pneumococci. 
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TExT-FIG.  9.  Experiment 7.  Strain IV M.4  ~.  The m.l.d, was o.oo,ooo, ooi cc. 
of a  24 hr. broth culture.  Dose  used:  IO m.l.d.  (Column A).  Column  B,  con- 
trols  (untreated). 
Comment on Experiment 7.--(Text-fig.  9.)  No  further  deaths 
occurred  after the  4th  day.  Of 8  animals  injected  with  IO  times 
the  m.  1.  d.  and  treated,  2  died  of toxicity  and  6  survived.  This 
was an unusually virulent strain of Group IV.  The virulence, how- 
ever,  rapidly  fell off on artificial  cultivation. 
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TExT-FIG.  IO.  Experiment  8.  Strain  South  Africa  (9).52.  The  m.l.d,  was 
o.oi  cc.  Doses  used:  Io  m.l.d.  (Column  A) ;  20  m.l.d.  (Column  B) ;  50  m.l.d. 
(Column  C).  Column D,  controls  (untreated). 
Comment  on Experiment 8.--(Text-fig.  IO.)  Of  the  mice  in- 
fected with  IO times the m.  1. d.  and treated all survived;  of those 
infected with 20 times the m.  1. d.  and treated  only  I  died of pneu- 
mococcal  septicemia,  all  the  others  surviving;  all  those  infected 
with  5  °  times  the  m.  1.  d.  and  treated  survived.  The  controls  in- 
fected with  I  m.  1.  d.  all died within 48 hours. Henry  F.  Moore.  283 
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TExT-FIG.  II.  Experiment 9-  Strain  IV  (S  lO)319.  The  m.l.d, was o.oi  ce. 
(48  hrs.).  Dose used :  io m.l.d.  (Column A) ;  50  m.l.d.  (Column  B).  Column 
C,  controls,  I  m.l.d.  (untreated). 
Comment on Experiment 9.--(Text-fig.  II.)  Of the  5 animals 
infected with im. 1. d. and treated 2 survived, and 3 died of toxicity. 
From  the  heart's  blood  of  one  of  these  latter  a  Gram-negative 
bacillus  was  recovered.  One  died  of  pneumococcal  septicemia. 
Both  the  animals  infected  with  5  °  times  the  m.  1.  d.  and  treated 
recovered. 
DISCUSSION. 
The  results  of the  present  study agree,  in  the  main,  with  those 
of the other workers mentioned.  We have not had  in our experi- 
ments  such a  large  percentage  of  cures  as  is  claimed  by Morgen- 
roth,  namely 9 °  to IOO per cent; nor have we seen any definite pro- 
tective  action  of  optochin  in  vivo  with  an  amount  of  infection 
greater  than  I,OOO times  the  m.  1.  d.  of  a  highly  virulent  strain. 4 
Moreover,  the  greater  the  virulence  of  the  strain  (by  passage 
through  mice)  the  greater  was  the  difficulty in  protecting  against 
increasing multiples of the m.  1. d.  Constant results are difficult to 
obtain  in  the  mouse,  owing  to  the  repeated  injections  apparently 
causing  the  animals  a  considerable  degree  of traumatism  and  con- 
sequently  rendering  them  liable  to  intercurrent  troubles.  This. 
was  true  of  an  epidemic  of  mouse  typhoid  which  tended  to 
obscure the  results.  The  relative  toxicity of the  drug  for  mice  is 
another  factor which tends  to render  results not quite clear.  Olive 
oil,  the  vehicle  in  which  the  drug  is  given,  does  not  undergo 
absorption  for a  week or more,  and  the  disturbance  to the  tissues 
caused by the repeated injections of this  inert body seems to afford 
4 See  page 281, footnote 3- 284  Action of Ethylhydrocuprein  on Pneumococci. 
a  suitable  nidus  for  the  growth  of  bacteria  which  may  kill  the 
animal  before the  observation  is  concluded.  It  seems  likely that 
the  detrimental  factors,  toxicity  of  the drug,  the  traumatism  in- 
flicted by the injections, and the effect of the infection itself, sum- 
mate in their effects and thus render the probability of the animal 
surviving less  likely, although its  body may have been  completely 
sterilized from pneumococcal infection.  The effect of ethylhydro- 
cuprein in  vitro  and  in  vivo  on  the  pneumococcus is  considerable 
and  specific  and  is  seen  on  type  strains  of  all  four  groups  of 
pneumococci. 
From  the  text-figures  it  is  seen  that,  of  85  mice infected with 
IOO times the m. I. d. or less and treated,  15  mice, or 17.6 per cent, 
died of pneumococcal septicemia;  13 mice, or 15.2  per cent, died of 
toxicity of the drug or some obscure cause, the heart's blood being 
sterile  at  autopsy  (the  corresponding  controls  invariably  died  of 
pneumococcal septicemia) ; 56 mice, or 66.8 per cent, survived.  Of 
these 85  treated mice, 69,  or 81  per cent,  either recovered or died 
of causes other than pneumococcal septicemia; such, for example, as 
the toxicity of the drug. 
CONCLUSIONS. 
I.  Ethylhydrocuprein hydrochloride in very high dilution inhibits 
the  growth  of,  and  in  18  hours  kills,  representatives  of  all  four 
groups of pneumococci in vitro.  The killing effect is generally seen 
in  somewhat lower  dilutions  than  the  inhibiting  effect.  No  con- 
stant  or  considerable difference is  seen  in  these  actions  on  repre- 
sentatives of the  four groups  of the pneumococci.  The  action of 
ethylhydrocuprein hydrochloride on the pneumococci in vitro  is  so 
strongly specific that  it  may possibly be used  as  a  test  for a  true 
pneumococcus. 
2.  The inhibitory or killing effects of ethylhydrocuprein hydro- 
chloride in vitro on bacteria other than pneumococci are slight or ab- 
sent.  The  effects are  greater  on  streptococci than  on  any other 
organisms  examined, but  are still  much less  than  on  the pneumo- 
cocci.  This  action distinguishes between the streptococcus group, 
including  Streptococcus  mucosus  sometimes  found  in  normal Henry  F.  Moore.  285 
mouths,  on  the  one  hand,  and  the  true  pneumococcus  (including 
Pneumococcus mucosus), on the other. 
3.  Quinine  hydrochloride inhibits  the  growth of,  and  kills  the 
pneumococcus in vitro; much stronger concentrations, however, are 
necessary than  in  the  case  of  ethylhydrocuprein.  This  effect of 
quinine hydrochloride is also seen on other organisms, but in a  less 
degree. 
4-  Ethylhydrocuprein  (optochin base)  has  a  well  marked pro- 
tective action against experimental pnemnococcal infection in mice 
in the case of type strains of all  four groups of pneumococci; this 
protective  action  may  be  efficient  against  many multiples  of  the 
minimum  lethal dose. 
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